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From summary and commentary
Drug safety testing was piloted at a UK festival
in 2016, enabling attendees to submit their
illicit drugs for forensic testing and receive
harm reduction advice.
In total, 20% of drugs were not what they were
sold as, and this mis-selling was twice as high
when drugs were bought at the festival than
when they were bought offsite.
Upon hearing the test results, one in five
service users chose to dispose of their drugs,
and targeted alerts were disseminated with the
support of festival management and police,
including for chloroquine and ketamine mis-sold
as cocaine, and pills with high MDMA content.
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In a year when drug-related deaths in the UK had peaked, a pioneering study of drug safety testing was
conducted on festival grounds. Its impact on drug-related harm was measured at various levels, including
drug-related hospital admissions, behaviours of 230 people who received harm reduction advice, and
actions that stakeholders took after receiving information about drugs being mis-sold or contaminated.
SUMMARY
In 2016, a year when UK drug-related deaths and festival drug-related deaths reached their highest on
record to date, a drug safety testing service was piloted on the grounds of a festival with the aim of
reducing drug-related harm.
Drug safety testing has existed in various forms for over
50 years, enabling the general public to submit illicit
drugs for content analysis. The drive for drug safety
testing has stemmed from concerns about specific drugs
and drug use in specific contexts, for example new
psychoactive substances entering the market, the
contamination of drug markets with fentanyl, and the
advent of acid house, rave, and electronic dance music
and associated use of synthetic ‘party drugs’ such as
MDMA (ecstasy).
Uniquely, drug safety testing can close the gap between
what people think they are taking and what they are
actually taking. However, for critics, conducting forensic
analyses in challenging conditions means that at best
drug safety testing gives an illusion of safety, and at worst
can provide dangerously inadequate test results given the
inevitable trade-off between speed, accuracy, reliability
and portability of equipment. Further concerns include: a
focus on risky substances (particularly contaminants) at
the expense of risky behaviours (such as bingeing and
polydrug use); the potential for non-enforcement of drug controls within a police ‘tolerance zone’ to be the
‘thin end of the wedge’ to decriminalisation; and a broader, more nebulous concern about drug safety
testing ‘normalising’ attitudes to drug use amongst the wider population.
Though it is also known as ‘drug checking’, drug safety testing is the preferred term by British stakeholders
as it emphasises the aim to help keep the public safe and distinguishes it from testing for surveillance
purposes such as in prisons or workplaces, and from checking drugs which may evoke assisting or
encouraging a crime (see Serious Crime Act 2007).
Multi-agency safety testing, the model of drug safety testing developed in the UK, is distinctive in that: (1)
it foregrounds the sharing of test results with onsite and offsite stakeholders with the agreed aim of
reducing drug-related harm; and (2) test results are delivered by healthcare staff in the context of a
discussion with the client which takes the form of a brief intervention aiming to reduce drug-related harm.
In this pilot, multi-agency safety testing was run out of a large tent in the designated welfare area of a
festival, alongside paramedic and other health and wellbeing services. Police agreed to this being a
‘tolerance zone’, where members of the public could bring any substances of concern for testing and receive
results as part of an individually tailored brief intervention.
• The testing worked by service users putting a dose – a pill or approximately 5 mg of powder (but not
vegetable or fungal matter) – into a small plastic bag which they sealed and posted in a locked amnesty bin
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that was regularly taken and emptied in the lab. They received a unique ID number and were asked
to return about an hour later.
• Brief interventions (lasting approximately 15/20 minutes) followed a predetermined structure: a
scripted general warning about all drug use carrying risks and drug use not being encouraged or
facilitated by the service; medical and drugs histories; current drinking and use of drugs and
medications; what the sample was bought as, what it was thought to be, and what the test revealed
it to be; as well as harm reduction advice tailored to the individual and their consultation. Risky
behaviours such as bingeing, polydrug use and specific drug combinations of concern were also
discussed. In addition, there were opportunities for questions, free harm reduction leaflets, and
onwards signposting to a local drugs service.
• Finally, all service users were offered the opportunity to use a disposal service whereby further
substances of concern in their possession could be handed over for onward safe destruction by the
police.
Main findings
A total of 230 brief interventions were delivered, with a further 17 forensic test results not collected
by service users. People tended to visit the testing service in friendship groups of four, resulting in
harm reduction advice embedded in the local drug market context being distributed directly to
roughly 900 service users. This equated to approximately one in five drug users at that festival,
based on the estimated 21% of UK festival-goers taking illegal drugs.
Over half of service users were male (66%), most (87%) self-identified as White, and the average
age was 28 years old. Service users who were taking ketamine tended to be younger (24 years)
than MDMA (28 years) and cocaine (28 years) users.
Just 5% reported having previously accessed support or treatment from a healthcare professional for
their drinking or drug use. Half (50%) of service users bought or acquired their substance offsite and
successfully smuggled it past security search procedures at entry. The other half (48%) bought or
acquired their substance from a friend, acquaintance, or dealer within the festival grounds.
Tests revealed that 37% of samples were MDMA crystal/powder and 20% pills, 14% ketamine, and
10% cocaine, with one in five samples (20%) not what they were sold as. Substances acquired
within the festival grounds were more than twice as likely to be at variance with what they were sold
as compared with those bought offsite (27% vs. 12%).
In terms of mis-sold substances:
• Some samples were revealed to be cheaper psychoactive drugs mis-sold as more expensive drugs,
for example ketamine mis-sold as cocaine which has up to double the street price and greater
criminal penalties in the UK, resulting in a higher reward-to-risk ratio for a dealer, and cathinones
mis-sold as cocaine, ketamine, or MDMA.
• A number of samples contained pharmaceuticals and ‘cutting agents’ including chloroquine (a
prescription anti-malaria medicine), benzocaine, caffeine, ephedrine, and paracetamol, all mis-sold
as cocaine.
• Other mis-sold samples contained inactive but relatively harmless ingredients such as six samples
of plaster of paris mis-sold as ecstasy pills and four samples of brown sugar mis-sold as MDMA
crystal.
Upon hearing the test result, one in five service users (21%) chose to use the disposal service. Two
thirds of those whose test result revealed their sample to be at variance with what it was sold as
then handed over further substances in their possession compared with one in ten whose sample
was confirmed to be as sold (67% vs. 9%). Those who obtained their sample within the festival
grounds were nearly twice as likely to use the disposal service as those who obtained their sample
offsite (27% vs. 15%).
Other outcomes included 22 service users saying that they would take the substance over a longer
time period or after leaving the festival, and another seven said that they intended to take a smaller
quantity of the drug. For most of these their test result confirmed the substance to be as sold but of
a higher strength than anticipated, with the consultation session providing an opportunity for
healthcare staff to discuss estimated strength and appropriate dosage. Six respondents reported
their intention to throw away further substances in their possession after hearing the test result.
Through daily security advisory group meetings, all onsite agencies at the festival (including police,
welfare, security and paramedical services) were updated on the results of drug testing, which
revealed significant mis-selling onsite. This prompted the circulation of targeted alerts with the
support of festival management and police, including for chloroquine and ketamine mis-sold as
cocaine, and pills with high MDMA content.
The year that multi-agency safety testing was introduced, the festival reported a 95% reduction in
drug-related hospital admissions from the previous year (one admission versus 19 in 2015). Festival
and partner agencies suggested a number of possible explanations for this fall:
• heightened awareness of contaminants in circulation and mis-selling onsite;
• early presentation for drug-related problems combined with a greater confidence amongst
paramedics in treating drug-related presentations onsite rather than sending people to hospital.
The authors’ conclusions
Overall, the findings of the pilot study suggested that: festival-goers engage productively with onsite
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drug safety testing services when given the opportunity; such services can access harder-to-
reach or new user groups; and can play a part in reducing drug-related harm by identifying
and informing service users, emergency services, and offsite drug-using communities about
substances of concern. Use of the disposal service for destruction of substances by the police
provided an externally corroborated measure of impact, reducing harm to the individual and
others by removing such substances from site.
One of the implications of the findings is for future policing. Security procedures combined
with onsite dealing practices could significantly increase drug-related harm as drugs bought
onsite were more than twice as likely to be mis-sold as those bought offsite.
COMMENTARY The aim of the piloted drug safety testing service was to reduce
drug-related harm – in part by closing the gap between what people think they are taking
and what they are actually taking. As with other harm reduction interventions, its full impact
was difficult to measure. Researchers tend to undertake evaluations of harm reduction in
real-world settings, in which the effects of the interventions are obscured by a complex set of
factors not under their control, as opposed to meeting the scientific ‘gold standard’ of a
randomised controlled trial, where participants are randomly assigned to an intervention
versus an alternative intervention or no intervention at all. Despite this, it may be possible to
at least estimate the likelihood that an intervention (in this case, drug safety testing) is
having a positive or negative impact. For instance, it may not be possible to determine
impacts on risky drug use in general, but it is possible to observe impacts on indicators of
risky drug use such as drug-related hospital admissions, or indicators of positive health
choices such as choosing to dispose of drugs that were mis-sold or contaminated. Another
issue related to measuring impact is that advice given to people attending a harm reduction
service may subsequently be passed on through word-of-mouth to peers and elicit a change
in the behaviour of people in the wider drug-using population. This means that the baseline
attitudes, beliefs, or behaviours of the wider population may not provide a true no-
intervention group with which to compare and therefore reduce the power of the study to
detect positive outcomes.
Weighing up how to measure impact in the present study, the author noted that while “a
reduction in drug-related deaths could be considered a clear measure of positive behavioural
outcomes”, drug-related deaths are relatively rare at festivals and often influenced by many
factors. A perceived “more useful measure of efficacy” at the festival population level was
drug-related hospital admissions (incidents requiring major critical care), for which there was
a drop between 2015 and 2016 (from 19 to one). However, these figures could also have
been influenced by factors outside of or in addition to harm reduction advice received from
staff at the drug safety testing service.
According to a 2017 market research report based on a sample of 8,000 festival-goers, one in
five (20.9%) admitted to taking illicit drugs at a festival and 1.3% to taking ‘legal highs’ (now
known as new psychoactive substances). While security measures may be in place to try and
eradicate drug possession and drug use onsite, the featured pilot found that they may be
counterproductive. For instance, searching for drugs on entry combined with dealers on the
festival site who have managed to smuggle substances in may encourage onsite purchases
which could increase drug-related harm, as drugs bought onsite were more than twice as
likely to be misrepresented.
The evolution of multi-agency safety testing, the pilot drug safety testing service run by the
not-for-profit organisation The Loop, was described in a  on reducing drug-related harm
in the night time economy:
From 2010 onwards [Fiona Measham, the author of the featured paper, Professor
of Criminology at Durham University, and co-founder/Director of The Loop]
shadowed Home Office and academic scientists who conducted forensic analysis
‘back of house’ or behind the scenes at festivals and nightclubs primarily for
intelligence and evidential purposes and to collect drug market trend data. In 2013
The Loop was founded and started forensic testing behind the scenes for police and
paramedics at a number of UK festivals and nightclubs, using similar equipment
and analytical methods[…], to share intelligence with partner organisations and to
reduce drug-related harm both on and off site. This ‘halfway house’ model of
testing expanded the sample gathering and intelligence sharing from primarily
police to paramedics and other stakeholders (1). It is this ‘halfway house’ model of
onsite testing as a collaboration between stakeholders but without public access
that has been recommended by the Victoria Parliament’s recent inquiry (2).
In 2016 the general public were added to this reciprocal information-sharing
process and with police support, were able to bring samples for testing too, in a
new ‘front of house’ testing service coined Multi Agency Safety Testing (MAST). The
Loop’s MAST service places strong emphases on both the brief interventions
delivered by experienced healthcare professionals ahead of disseminating test
results, and also on the collaborative, multi agency partnership approach to the
testing service. Test results and trend data are shared with partner organisations
report
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both on and off-site, as well as alerts issued on and off-site, with an overall
aim of reducing drug-related harm at leisure events and more widely
through greater monitoring of illegal drug markets. The Loop’s protocol is
designed to operate within UK law and multi-agency safety testing only
operates after obtaining the full support of police, public health, local
authorities, event organisers and other stakeholders.
Partners of The Loop include Release (the national centre of expertise on drugs and
drugs law), Cambridgeshire Police, Cumbria Constabulary, and the Royal Society for
Public Health.
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